Enhanced Closes Initial Tranche of $50 Million Financing

Key Terms

private investment in public equity (pipe) financial

A private investment in public equity (PIPE) is when a publicly traded company sells new shares or instruments that can become shares directly to a small group of private investors instead of through the open market. Think of it like a company taking a private loan from a few investors rather than holding a big public sale; it raises cash fast but can dilute existing owners and signal either financial need or strong backing by informed investors.

telehealth medical

Telehealth is the delivery of healthcare services and consultations remotely using video calls, phone, text messaging, or connected devices to monitor and transmit medical information. It matters to investors because it can reshape how patients access care, lower costs, and create new revenue streams or risks for healthcare providers, insurers and technology companies—similar to how online banking changed financial services—while also exposing businesses to reimbursement and regulatory shifts.

peptides medical

Peptides are short chains of amino acids—the building blocks of proteins—that act like tiny messengers or tools in the body to trigger or block biological processes. Investors care because peptides are used as medicines, diagnostics, and research tools with potential for targeted treatments, often faster and cheaper to develop than large proteins; their commercial value depends on clinical results, manufacturing scalability, patent protection and regulatory approval.

food & drug administration (fda) regulatory

A federal agency that evaluates and approves foods, medicines, medical devices and cosmetics to ensure they are safe and work as claimed; think of it as the country’s gatekeeper for health products. Its decisions matter to investors because approval or rejection, safety warnings, or changes in rules can quickly change a product’s ability to reach customers, a company’s costs and legal exposure, and therefore its sales, stock price and risk profile.

pharmacy compounding advisory committee regulatory

A pharmacy compounding advisory committee is a government-appointed panel of independent experts who review practices, safety data and proposed rules about how pharmacies prepare customized medicines for individual patients. Its advice matters to investors because the committee’s recommendations can lead to new regulations or enforcement priorities that change the cost, supply and legal risk for compounding pharmacies, hospitals and drugmakers—like a neighborhood council whose decisions affect who can operate and how.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Company’s Sports Business and Live Enhanced Consumer Platform Continue to Gain Momentum

Company Expects to Be Fully Funded Through Profitability in 2027

NEW YORK--(BUSINESS WIRE)-- Enhanced Group Inc. (“Enhanced” or the “Company”) (NYSE: ENHA) today announced the successful closing of the initial tranche of its previously disclosed $50 million private investment in public equity (PIPE) financing. The remaining tranches are expected to close following customary regulatory and stock exchange approvals. The financing is led by Apeiron Investment Group, the family office of Enhanced Co-Founder and Chairman Christian Angermayer, with participation from Co-Founder and CEO Maximilian Martin, with ticket sizes of $20 million and $5 million respectively, as well as leading global institutional investors. Martin has provided a piece on substack regarding his investment decision.

Enhanced's strategy brings together a global sports property and an integrated consumer telehealth platform, built so that each reinforces the other. Management believes the financing provides the Company with a clear path to operational profitability in 2027 while accelerating the buildout of what it believes can become the world's leading Performance Medicine platform.

The Enhanced Games create global attention. Athlete performance provides proof of concept. The Enhanced Medical program creates the trust. The brand creates aspiration. The Company’s consumer platform Live Enhanced converts that attention and trust into recurring consumer demand.

The inaugural Enhanced Games have already delivered a compelling proof point for this strategy. The Games generated more than $32 million of aggregate sponsorship contract value - exceeding internal estimates with more than seven months still left in the year. The Games also reached more than one billion people globally, demonstrating the unique ability of the Enhanced brand to generate attention at a scale that most emerging sports properties would require hundreds of millions, if not billions of dollars in marketing to achieve.

Following the success of the inaugural Games, existing sponsors have expressed interest in renewing for 2027, while inbound demand from prospective sponsors continues to accelerate. The Company currently expects the sports business to achieve profitability in 2027.

Live Enhanced is built around the same mission as the Games: helping people move from baseline to best through personalized, medically supervised performance enhancements. The Company is already seeing encouraging early evidence that the trust, aspiration, and engagement generated by the brand are translating into superior consumer economics. For example, first-time customers are entering the Live Enhanced platform with meaningfully higher order values than traditional telehealth industry benchmarks. Management believes one of the largest long-term opportunities within the platform could be peptides, which it expects to become one of the defining consumer health categories of the coming decade. The upcoming meeting of the Food & Drug Administration (FDA) Pharmacy Compounding Advisory Committee on July 23-24, is expected to discuss potential regulatory changes affecting compounded peptide products, and could represent an important industry inflection point that generates regulatory tailwinds for the Live Enhanced platform.

About Enhanced Group, Inc.

Enhanced (NYSE: ENHA) is an elite sports competition and performance products company committed to giving athletes and people alike access to products that optimize their health, performance and recovery. The Live Enhanced platform provides consumers access to products, and protocols that optimize health, longevity and vitality. As a premium brand, Enhanced aims to revolutionize and lead the Performance Medicine category. For more information about the mission of Enhanced please visit www.enhanced.com

Transaction Advisors

Cantor is serving as exclusive placement agent. DLA Piper LLP (US) is serving as legal advisor to Cantor. Cooley is serving as legal advisor to Enhanced.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, about Enhanced and Enhanced’s industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release are forward-looking statements, including, but not limited to, statements regarding: Enhanced’s expected cash runway and future profitability; the total gross proceeds that Enhanced expects to receive in the PIPE; Enhanced’s intended use of proceeds from the PIPE; future prospects of the Enhanced Games, including future partnerships and sponsorships and the occurrence of additional sporting events; the closing of the PIPE; the impact of the sports business on the Live Enhanced consumer platform and the benefits and impact of such platform; and management’s belief that it will be able to reduce customer acquisition costs; the ability of the proceeds to the Company from the PIPE being able to accelerate Enhanced’s growth, scale its platform aggressively, and execute on its path to profitability; and the de-risked investment case in Enhanced as a result of the Enhanced Games. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “going to,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions. Enhanced cautions you that the foregoing may not include all of the forward-looking statements made in this press release.

You should not rely on forward-looking statements as predictions of future events. Enhanced has based the forward-looking statements contained in this press release primarily on its current expectations and projections about future events and trends that it believes may affect Enhanced’s business, financial condition, results of operations and prospects. These forward-looking statements are subject to risks and uncertainties related to: Enhanced’s financial performance; the ability to attract and retain athletes, sponsors and partners; managing Enhanced’s growth and future expenses; competition and new market entrants; compliance with new laws and regulations; the ability to attract and retain qualified team members and key personnel; the ability to access additional financing; completed and future acquisitions, divestitures or investments; the potential adverse impact of natural disasters, health epidemics, macroeconomic conditions, and war or other armed conflict, as well as risks, uncertainties, and other factors described in the section titled “Risk Factors” in Enhanced’s filings with the SEC, as well as in other filings Enhanced may make with the SEC in the future. In addition, any forward-looking statements contained in this press release are based on assumptions that Enhanced believes to be reasonable as of this date. Enhanced undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260618237684/en/

Media Contact
media@enhanced.com

Source: Enhanced Group Inc.